Jd. Lloydstill et al., THE EFFECT OF INTESTINAL PERMEABILITY ON PANCREATIC ENZYME-INDUCED ENTEROPATHY IN THE RAT, Journal of pediatric gastroenterology and nutrition, 26(5), 1998, pp. 489-495
Background: Fibrosing colonopathy in cystic fibrosis occurs in childre
n 2 to 7 years old and is associated with excess doses of high and reg
ular strength lipase pancreatic enzymes, given for more than 6 months.
A rat model was developed to study the effects of excessive doses of
pancreatic enzymes equivalent to those producing fibrosing colonopathy
in cystic fibrosis patients. Methods: Five groups of animals were stu
died after administration of different combinations of pancreatic enzy
mes, oleic acid, and reserpine. Results: Pancreatic enzymes alone prod
uced minimal damage to the intestine and none to the liver. Excessive
doses of pancreatic enzymes in combination with agents that increased
intestinal permeability (oleic acid, reserpine) were associated with i
ntestinal eosinophilia and necrosis of the jejunoileal muscle layer an
d inflammatory nodules in the liver, which increased with duration of
insult. Conclusions: Increased intestinal permeability potentiates dam
age to the intestine caused by excessive pancreatic enzyme dosage. It
is a characteristic of cystic fibrosis that may increase vulnerability
to fibrosing colonopathy.